Yew Bio-Pharm Group, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced total revenue was USD 9.562 million compared to USD 12.565 million a year ago. Operating income was USD 856,500 compared to USD 1.136 million a year ago. Net income was USD 737,567 compared to USD 1.436 million a year ago. Basic earnings per share from continuing operations was USD 0.01 compared to USD 0.03 a year ago. For the half year, total revenue was USD 11.591 million compared to USD 24.079 million a year ago. Operating income was USD 1.013 million compared to USD 1.681 million a year ago. Net income was USD 888,979 compared to USD 1.813 million a year ago. Basic earnings per share from continuing operations was USD 0.02 compared to USD 0.03 a year ago.